Yller Biomateriais
A Brazilian dental materials company specializing in 3D printing resins and high-performance biomaterials for dental applications, recognized as the first Brazilian manufacturer to produce 3D printing resins for dental use.
- CEO / Founder
- Fabricio Ogliari
- Team Size
- 51-200
- Stage
- Subsidiary
- Total Funding
- $1.0M
- Latest Round
- Acquired
- Key Investors
- Crescera Capital (via Criatec 2 fund), Bozano Investimentos
Technology & Products
Key Products
Yller Biomateriais develops and sells consumable dental materials including adhesives, resins (Cosmos line for 3D printing, Cosmos Plus Full Arch, CosmosSplit, CosmosTemp), silicones, sealants, dental cements, and whiteners. They offer 3D printing resins for surgical, prosthetic, and orthodontic indications, as well as a comprehensive family of addition and condensation silicones for molding.
Technological Advantage
Combines deep biomaterials research capabilities (polymer chemistry, nanotechnology) with practical dental industry applications; resins feature low viscosity for easy equipment cleaning, high polymerization speed for faster production, and excellent dimensional stability; integrated within Straumann Group's global digital dentistry ecosystem.
Differentiation
Value Proposition
Delivers innovative, locally manufactured dental biomaterials with significant R&D investment; provides Brazil's first domestically produced 3D printing resin line (Cosmos) for SLA, DLP, and LCD technologies; offers technical education and support platform (YllerDigital) alongside high-quality products.
How They Differentiate
First Brazilian manufacturer to produce 3D printing resins (SLA/DLP/LCD) for dental applications; combines university-level biomaterials research expertise with practical commercial scale; products feature low viscosity for easy equipment cleaning, high polymerization speed for faster production, and excellent dimensional stability; integrated within Straumann Group's global digital dentistry ecosystem as Cosmos resins.
Market & Competition
Target Customers
Dental professionals, dental clinics, dental laboratories, and prosthodontists
Industry Verticals
["Dental and Oral Healthcare","Medical Devices","3D Printing/Additive Manufacturing","Digital Dentistry"]
Competitors
AVITA Medical, Acelity, Bio-Tissue, Straumann Group, Dentsply Sirona, Zimmer Biomet, Geistlich Pharma, 3M, Ivoclar Vivadent, GC Corporation, Kuraray Noritake Dental.
Growth & Milestones
Growth Metrics
Acquired by Straumann Group (via Neodent) in December 2019; approximately $4 million annual revenue (2025 estimate); 51-200 employees (3,235 LinkedIn followers); exports expanded to European markets including DEI Itália.
Major Milestones
["Founded in 2012 by Fabrício and Aline Ogliari","First Brazilian dental industry to manufacture 3D printing resins (SLA, DLP, LCD technologies)","Launched Cosmos product line for 3D printing resins and high-performance silicones","Seed investment of R$1.00M led by Crescera Investimentos on May 1, 2018","Acquired by Neodent/Straumann Group in December 2019 (100% acquisition)","Cosmos resins integrated into Straumann's global digital dentistry ecosystem","Expanded internationally with exports to European markets","Continued R&D operations in Pelotas, Rio Grande do Sul, Brazil as Straumann subsidiary"]
Notable Customers
Angelus (national market), DEI Itália (Italian company active in the European market).